Antiviral Drugs - Sudan

Sudan

The projected revenue for Sudan's Antiviral Drugs market is expected to reach US$2.29m in 2024.
This indicates a steady growth rate of -0.09% annually (CAGR 2024-2029), resulting in a market volume of US$2.28m by 2029.
When compared globally, United States is anticipated to generate the highest revenue with US$30,640.00m in 2024.
Sudan's demand for antiviral drugs has surged due to the increasing prevalence of infectious diseases in the country.

Key regions: Brazil, India, Australia, United States, United Kingdom

Market

Region

Region comparison

Currency

Analyst Opinion

Antiviral drugs are medications used to treat viral infections and have been in high demand since the outbreak of the COVID-19 pandemic. In Sudan, the Antiviral Drugs market has been steadily developing due to various factors.

Customer preferences: Customers in Sudan have shown an increased demand for antiviral drugs due to the recent COVID-19 pandemic. The pandemic has led to a rise in awareness regarding the importance of antiviral drugs, leading to an increase in demand.

Trends in the market: The Antiviral Drugs market in Sudan has been growing steadily due to the rise in demand for antiviral drugs. The market is expected to grow further due to the development of new antiviral drugs and the increasing number of people affected by viral infections. The rise in investment in research and development of antiviral drugs is another factor driving the growth of the market.

Local special circumstances: Sudan has been facing various challenges in the healthcare sector, including a lack of healthcare infrastructure and limited access to healthcare facilities in remote areas. The COVID-19 pandemic has further highlighted the need for investment in the healthcare sector, including the development of antiviral drugs.

Underlying macroeconomic factors: The Sudanese economy has been recovering from the effects of the civil war and the separation of South Sudan. The country has been implementing economic reforms to attract foreign investment and improve economic growth. The development of the Antiviral Drugs market in Sudan is expected to contribute to the growth of the healthcare sector and the overall economy.In conclusion, the Antiviral Drugs market in Sudan has been growing steadily due to the rise in demand for antiviral drugs, the development of new drugs, and the increasing investment in research and development. The market is expected to continue growing, contributing to the growth of the healthcare sector and the overall economy.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.

Modeling approach / Market size:

Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.